Your email has been successfully added to our mailing list.

×
0.0804838709677418 0.0514516129032257 0.0161290322580645 0.00677419354838707 -0.0161290322580645 0.0322580645161291 0.0161290322580645 -0.0446774193548388
Stock impact report

U.S. FDA Grants Orphan Drug Designation (ODD) for Quilience(R) (Mazindol ER) for the Treatment of Idiopathic Hypersomnia (IH)

NLS Pharmaceutics Ltd. - Common Shares (NLSP) 
Company Research Source: Accesswire
ODD for IH in the U.S. follows July 2022 grant of ODD for treatment of IH in EuropeCurrently only 1 drug approved in the United States to treat IH while no drugs are currently approved in Europe for IHHigh unmet medical need in this rare indicationZURICH, SWITZERLAND / ACCESSWIRE / November 2, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that it has received Orphan Drug Designation ("ODD") from the FDA in the United States for Mazindol, the active ingredient in its lead product candidate, Quilience® (Mazindol ER) for the treatment of Idiopathic Hypersomnia ("IH"). ODD is granted by the U.S. Food and Drug Administration ("FDA") to encourage the development of treatments for diseases or conditions that affect fewer than 200,000 patients in the United States. Drug pr Show less Read more
Impact Snapshot
Event Time:
NLSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NLSP alerts
Opt-in for
NLSP alerts

from News Quantified
Opt-in for
NLSP alerts

from News Quantified